Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice

MLA

Lorne A. Babiuk, et al. “Protein-Prime/Modified Vaccinia Virus Ankara Vector-Boost Vaccination Overcomes Tolerance in High-Antigenemic HBV-Transgenic Mice.” Vaccine, vol. 34, Feb. 2016, pp. 923–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f96af9c9463556fc378a968368e39873&authtype=sso&custid=ns315887.

APA

Lorne A. Babiuk, Clemens Jäger, Ulrike Protzer, Simone Backes, Georg Gasteiger, Claudia J. Dembek, Dirk H. Busch, Anna D. Kosinska, Tanja Bauer, Andris Dislers, Ann-Sophie Stephan, & George Mutwiri. (2016). Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice. Vaccine, 34, 923–932.

Chicago

Lorne A. Babiuk, Clemens Jäger, Ulrike Protzer, Simone Backes, Georg Gasteiger, Claudia J. Dembek, Dirk H. Busch, et al. 2016. “Protein-Prime/Modified Vaccinia Virus Ankara Vector-Boost Vaccination Overcomes Tolerance in High-Antigenemic HBV-Transgenic Mice.” Vaccine 34 (February): 923–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f96af9c9463556fc378a968368e39873&authtype=sso&custid=ns315887.